Sientra, Inc.

SIEN

US82621J2042

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 01:32:01 2024-04-16 pm EDT			5-day change	1st Jan Change
0.0566 ^USD	-29.07%		-52.95%	-90.72%

Apr. 11	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 04	North American Morning Briefing : Focus Turns to -2-	DJ

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Sientra, Inc.

North American Morning Briefing : Stock Futures -2-	Apr. 11	DJ
North American Morning Briefing : Focus Turns to -2-	Apr. 04	DJ
Final DIP Financing Approved for Sientra, Inc.	Mar. 11	CI
Bidding Procedure Approved for Sientra, Inc.	Mar. 05	CI
Sientra, Inc.(OTCPK:SIEN.Q) dropped from NASDAQ Composite Index	Feb. 20	CI
Sientra, Inc.(NasdaqGS:SIEN) dropped from S&P TMI Index	Feb. 15	CI
Interim DIP Financing Approved for Sientra, Inc.	Feb. 14	CI
Motion for Joint Administration Approved for Sientra, Inc.	Feb. 13	CI
Health Care Limits Losses Amid Defensive Bias -- Health Care Roundup	Feb. 13	DJ
Sientra Shares Plunge After Company Seeks Sale of Business, Files for Bankruptcy	Feb. 13	MT
Motion for Asset Sale Filed by Sientra, Inc.	Feb. 12	CI
Sientra to Pursue Strategic Sale of Its Business Through Voluntary Chapter 11 Process	Feb. 12	CI
Motion for Joint Administration Filed by Sientra, Inc.	Feb. 11	CI
Sientra, Inc. Filed for Bankruptcy	Feb. 11	CI
Stifel Adjusts Price Target on Sientra to $2 From $4, Maintains Buy Rating	Nov. 13	MT
Transcript : Sientra, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Earnings Flash (SIEN) SIENTRA Reports Q3 Revenue $19.5M	Nov. 09	MT
Sientra, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
North American Morning Briefing : Fed Decision, -2-	Nov. 01	DJ
Craig-Hallum Downgrades Sientra to Hold From Buy, Cuts Price Target to $2 From $10	23-10-31	MT
Sientra, Inc. Provides Revenue Guidance for the Third Quarter of 2023	23-10-30	CI
Transcript : Sientra, Inc., Q2 2023 Earnings Call, Aug 10, 2023	23-08-10
Sientra, Inc. Revises Earnings Guidance for the Full Year 2023	23-08-10	CI
Earnings Flash (SIEN) SIENTRA Reports Q2 Revenue $23.1M, vs. Street Est of $25M	23-08-10	MT
Sientra, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI

Sientra, Inc. is a medical aesthetics company. The Company is engaged in transformative treatments and technologies focused on advancing plastic surgery. The Company provides medical aesthetics products to certified plastic surgeons and patients. It has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
SIENTRA, INC.	-90.72%	954K
ABBOTT LABORATORIES	-0.78%	189B
MEDTRONIC PLC	-3.80%	107B
BECTON, DICKINSON AND COMPANY	-5.26%	67.81B
DEXCOM, INC.	+10.02%	51.87B
CENCORA, INC.	+16.01%	46.67B
HOYA CORPORATION	-0.77%	38.68B
WEST PHARMACEUTICAL SERVICES, INC.	+7.77%	27.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+1.26%	26.6B
SARTORIUS STEDIM BIOTECH	+5.43%	26.34B